view8I Holdings Limited

8I Holdings acquiring stake in Singapore property and events management business


8I Holdings (ASX:8IH) has entered into a sale and purchase agreement to acquire 51% of Singapore-based property and events management business Hemus Pacific Private for S$2.4 million (A$2.2 million).

Hemus has been operating since 2005 with audited FY2013 revenue in excess of S$4.5 million.

It acquisition provides 8I with access to retail properties and events operated by Hemus.

These properties are typically located in retail shopping centres and mass transit interchanges with very high foot traffic.

Hemus specialises in operating promotional events in these locations, which can be synergised to provide 8IH with ongoing opportunities to attract enrolments for its financial education seminars and courses.

It operates as a master property manager for many locations in mass transit terminals and has close working relationships with public transport operators SBST and SMRT.

8I anticipates that relationships with these clients will provide 8IH with access to future property co-development and investment opportunities with prominent real estate owners and developers.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: 8I Holdings Limited

Price: 0.145 AUD

Market: ASX
Market Cap: $52.46 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Amryt Pharma presents at the Proactive One2One virtual conference

Amryt Pharma's LON:AMYT) Rory Nealon presents at the Proactive One2One virtual conference. Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases. The company...

8 hours, 47 minutes ago

2 min read